These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4310314)

  • 1. Intermittent corticotrophin therapy. Study of lymphocyte transformation in vitro in rheumatoid arthritis.
    Nelson SD; Mackay JS; Sheridan B; Weaver JA
    Ann Rheum Dis; 1969 Sep; 28(5):524-8. PubMed ID: 4310314
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent therapy with corticotrophin.
    Nelson JK; Mackay JS; Sheridan B; Weaver JA
    Lancet; 1966 Jul; 2(7454):78-83. PubMed ID: 4161024
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel.
    Besser GM; Butler PW; Plumpton FS
    Br Med J; 1967 Nov; 4(5576):391-4. PubMed ID: 4293374
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect and mode of faction of chlorambucil in rheumatoid arthritis. The importance of the lymphoblast transformation test.
    Bontoux D; Kahan A; Brouilhet H; Amor B; Delbarre F; Jouanneau M; Gniazdowska E
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):166-72. PubMed ID: 5552537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 6. An attempt at combining corticotrophin with long-term corticosteroid therapy. With a view to preserving hypothalmic-pituitary-adrenal function.
    Carter ME; James VH
    Ann Rheum Dis; 1970 Jul; 29(4):409-14. PubMed ID: 4318271
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of effects of corticotrophin and corticosteroids on pituitary-adrenal function.
    Carter ME; James VH
    Ann Rheum Dis; 1971 Jan; 30(1):91-7. PubMed ID: 4323367
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear antibody: predictive of lymphocyte response in rheumatoid arthritis.
    Menard HA; Dion J; Richard C
    J Rheumatol; 1977; 4(1):21-6. PubMed ID: 301940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: P.H.A. response and steroid therapy.
    Braeman J; Povey MJ
    Lancet; 1974 Jan; 1(7845):28. PubMed ID: 4129007
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermittent tetracosactrin-depot therapy in dermatology.
    Khan SA; Smith AF
    Br J Dermatol; 1970 Apr; 82(4):389-96. PubMed ID: 4315091
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent corticotrophin therapy. Integrity of pituitary-adrenal function.
    Mackay JS; Sheridan B; Weaver JA
    Practitioner; 1970 Nov; 205(229):646-51. PubMed ID: 4321736
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocytes in rheumatoid arthritis. I. Responses to allogeneic cells and to phytomitogens.
    Rawson AJ; Huang TC
    Clin Exp Immunol; 1974 Jan; 16(1):41-6. PubMed ID: 4283116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blastic transformation of lymphocytes stimulated with phytohemagglutinin (PHA) in patients with rheumatoid arthritis treated with azathioprine and cyclophosphamide].
    Mackiewicz S; Celińska-Szpytko E
    Pol Arch Med Wewn; 1974 May; 51(5):471-6. PubMed ID: 4832822
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. I. Porcine ACTH.
    Glass D; Daly JR
    Ann Rheum Dis; 1971 Nov; 30(6):589-92. PubMed ID: 4331738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of corticosteroids, androgens and their metabolites on the activation of lymphoid cells].
    Komissarenko VP; Vizirenko LV; Chebotarev VF; Tron'ko ND; Peretiatko TI
    Probl Endokrinol (Mosk); 1978; 24(1):120-3. PubMed ID: 634941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease of mitogen stimulation of lymphocytes in rheumatoid arthritis].
    Genth E; Kurze R; Nowak H; Franz K; Brude E; Hartl W
    Z Rheumatol; 1977; 36(5-6):168-79. PubMed ID: 899297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte transformation tests in patients under treatment with immunosuppressive drugs.
    Heine KM; Stobbe H; Klatt R; Apostoloff E; Dutz W
    Helv Med Acta; 1969 Nov; 35(2):140-5. PubMed ID: 4903255
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of plasma cortisol levels on the lymphocyte transformation test.
    Zeman GO; Cohen G; Budrys M; Williams GC; Javor H
    J Allergy Clin Immunol; 1972 Jan; 49(1):10-5. PubMed ID: 4331971
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormalities of peripheral blood lymphocytes in rheumatoid arthritis.
    Rawson AJ
    Rheumatology; 1975; 6():190-8. PubMed ID: 128109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of delayed-action beta 1-24 corticotropin in the therapy of rheumatoid arthritis].
    Liberti R; Longo C
    Policlinico Prat; 1970 Jan; 77(3):69-74. PubMed ID: 4314745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.